Basic Information
RNALocate ID: RLID:11002528
RNA Symbol: hsa-miR-378a-3p
Localization: Extracellular vesicle
RNA Information
RNA Name: hsa-miR-378
RNA ID: miRBase:MIMAT0000732
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 22849433
Tissue/Cell Line: HEK-293T cells
Method: Next-generation RNA sequencing
Description: The total numbers of reads >15 bp matching each miRNA were calculated. These values were then normalized to number of reads per million mapped (RPMM) in each library, to enable direct comparison of expression levels. As a measure of the relative levels of expression of individual miRNAs in cells and EVs, the log (base two) of the ratio of the read number in EVs over that in cells was calculated (log2 (EV/cell)). The miRNA expression data for cells and EVs is presented in Additional file 1: Table S1. Data are collected from Table S1.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002042 Cytoplasm LX-2 cells 31272073
RLID:01002043 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01002044 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01002045 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:01002046 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:11002516 Exosome Human cervical carcinoma cell line (HeLa|SiHa) 25760330
RLID:11002517 Exosome Human milk 28688106
RLID:11002518 Exosome Plasma 29323722
RLID:11002519 Exosome Peripheral blood 31746410
RLID:11002520 Exosome Serum 18589210
RLID:11002521 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11002522 Exosome HCC cell line (Hep3B|HepG2|PLC/PRF/5) 21721029
RLID:11002523 Exosome Ovarian follicular fluid 22116803
RLID:11002524 Exosome Brain tissue 23382797
RLID:11002525 Exosome Plasma 23663360
RLID:11002526 Exosome Human mast cell line (HMC-1) 24009880
RLID:11002527 Exosome Colon cancer cell line (LIM1863) 25330373
RLID:11002529 Microvesicle Plasma 23077538
RLID:11002530 Microvesicle Seminal plasma 23539611
RLID:11002531 Microvesicle Follicular fluid 23666971
RLID:11002532 Microvesicle Hepatoma cells 23771658
RLID-D:11000123 Exosome Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Saliva|Tongue tissue
RLID-D:11000420 Microvesicle Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-378a-3p Splenic marginal zone lymphoma MNDR-E-MI-46454
MNDR hsa-miR-378a-3p Oral squamous cell carcinoma MNDR-E-MI-46455
MNDR hsa-miR-378a-3p Small intestinal neuroendocrine tumor MNDR-E-MI-46456
MNDR hsa-miR-378a-3p High-grade serous ovarian carcinoma MNDR-E-MI-46457
MNDR hsa-miR-378a-3p Uterine corpus endometrial carcinoma MNDR-E-MI-46458
MNDR hsa-miR-378a-3p Lymphoma MNDR-E-MI-46459
MNDR hsa-miR-378a-3p Lymphoma non-hodgkin MNDR-E-MI-46460
MNDR hsa-miR-378a-3p Estrogen-receptor positive breast cancer MNDR-E-MI-46461
MNDR hsa-miR-378a-3p Estrogen-receptor negative breast cancer MNDR-E-MI-46462
MNDR hsa-miR-378a-3p Progesterone-receptor positive breast cancer MNDR-E-MI-46463
MNDR hsa-miR-378a-3p Progesterone-receptor negative breast cancer MNDR-E-MI-46464
MNDR hsa-miR-378a-3p Her2-receptor positive breast cancer MNDR-E-MI-46465
MNDR hsa-miR-378a-3p Breast cancer luminal MNDR-E-MI-46466
MNDR hsa-miR-378a-3p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-46467
MNDR hsa-miR-378a-3p B cell acute lymphoblastic leukemia MNDR-E-MI-46468
MNDR hsa-miR-378a-3p Small intestine cancer MNDR-E-MI-46469
MNDR hsa-miR-378a-3p Dermatomyositis MNDR-E-MI-46470
MNDR hsa-miR-378a-3p Prostate cancer MNDR-E-MI-46471
MNDR hsa-miR-378a-3p Gastric cancer MNDR-E-MI-46472
MNDR hsa-miR-378a-3p Alzheimer disease MNDR-E-MI-46473
MNDR hsa-miR-378a-3p Myotonic dystrophy MNDR-E-MI-46474
MNDR hsa-miR-378a-3p Head and neck cancer MNDR-E-MI-46475
MNDR hsa-miR-378a-3p Leukemia MNDR-E-MI-46476
MNDR hsa-miR-378a-3p Cardiovascular disease MNDR-E-MI-46477
MNDR hsa-miR-378a-3p Lung cancer MNDR-E-MI-46478
MNDR hsa-miR-378a-3p Parkinson disease MNDR-E-MI-46479
MNDR hsa-miR-378a-3p Basal-like breast cancer MNDR-E-MI-46480
MNDR hsa-miR-378a-3p Pituitary neoplasms MNDR-E-MI-46481
MNDR hsa-miR-378a-3p Pancreatic cancer MNDR-E-MI-46482
MNDR hsa-miR-378a-3p Melanoma MNDR-E-MI-46483
MNDR hsa-miR-378a-3p Rectum adenocarcinoma MNDR-E-MI-46484
MNDR hsa-miR-378a-3p Nephroblastoma MNDR-E-MI-46485
MNDR hsa-miR-378a-3p Colon cancer MNDR-E-MI-46486
MNDR hsa-miR-378a-3p Ischemic attack transient MNDR-E-MI-46487
MNDR hsa-miR-378a-3p Colon adenocarcinoma MNDR-E-MI-46488
MNDR hsa-miR-378a-3p Familial ovarian cancer MNDR-E-MI-46489
MNDR hsa-miR-378a-3p Prostate adenocarcinoma MNDR-E-MI-46490
MNDR hsa-miR-378a-3p Carcinoma ductal breast MNDR-E-MI-46491
MNDR hsa-miR-378a-3p Glioblastoma MNDR-E-MI-46492
MNDR hsa-miR-378a-3p Glioma MNDR-E-MI-46493
MNDR hsa-miR-378a-3p Osteosarcoma MNDR-E-MI-46494
MNDR hsa-miR-378a-3p Inclusion body myositis MNDR-E-MI-46495
MNDR hsa-miR-378a-3p Breast carcinoma MNDR-E-MI-46496
MNDR hsa-miR-378a-3p Liver cancer MNDR-E-MI-46497
MNDR hsa-miR-378a-3p Cervical adenocarcinoma MNDR-E-MI-46498
MNDR hsa-miR-378a-3p Gastric adenocarcinoma MNDR-E-MI-46499
MNDR hsa-miR-378a-3p Cervical squamous cell carcinoma MNDR-E-MI-46500
MNDR hsa-miR-378a-3p Pituitary adenoma MNDR-E-MI-46501
MNDR hsa-miR-378a-3p Lung squamous cell carcinoma MNDR-E-MI-46502
MNDR hsa-miR-378a-3p Lung adenocarcinoma MNDR-E-MI-46503
MNDR hsa-miR-378a-3p Ovarian carcinoma MNDR-E-MI-46504
MNDR hsa-miR-378a-3p Bladder urothelial carcinoma MNDR-E-MI-46505
MNDR hsa-miR-378a-3p Pancreatic adenocarcinoma MNDR-E-MI-46506
MNDR hsa-miR-378a-3p Carcinoma renal cell MNDR-E-MI-46507
MNDR hsa-miR-378a-3p Clear cell renal cell carcinoma MNDR-E-MI-46508
MNDR hsa-miR-378a-3p Large cell carcinoma MNDR-E-MI-46509
MNDR hsa-miR-378a-3p Intrahepatic cholangiocarcinoma MNDR-E-MI-46510
MNDR hsa-miR-378a-3p Cholangiocarcinoma MNDR-E-MI-46511
MNDR hsa-miR-378a-3p Esophageal cancer MNDR-E-MI-46512
MNDR hsa-miR-378a-3p Liver cirrhosis MNDR-E-MI-46513
MNDR hsa-miR-378a-3p Synovial sarcoma MNDR-E-MI-46514
MNDR hsa-miR-378a-3p Head and neck squamous cell carcinoma MNDR-E-MI-46515
MNDR hsa-miR-378a-3p Encephalomyelitis MNDR-E-MI-46516
MNDR hsa-miR-378a-3p Adenoma MNDR-E-MI-46517
MNDR hsa-miR-378a-3p Breast invasive carcinoma MNDR-E-MI-46518
MNDR hsa-miR-378a-3p Hepatocellular carcinoma MNDR-E-MI-46519
MNDR hsa-miR-378a-3p Familiar ovarian carcinoma MNDR-E-MI-46520
MNDR hsa-miR-378a-3p B-cell lymphoma MNDR-E-MI-46521
MNDR hsa-miR-378a-3p Rheumatoid arthritis MNDR-E-MI-46522
MNDR hsa-miR-378a-3p Retinoblastoma MNDR-E-MI-46523
MNDR hsa-miR-378a-3p Ulcerative colitis MNDR-E-MI-46524
MNDR hsa-miR-378a-3p Burkitt lymphoma MNDR-E-MI-46525
MNDR hsa-miR-378a-3p Tonsil cancer MNDR-E-MI-46526
MNDR hsa-miR-378a-3p Skin cutaneous melanoma MNDR-E-MI-46527
MNDR hsa-miR-378a-3p Skin melanoma MNDR-E-MI-46528
MNDR hsa-miR-378a-3p Acute myelocytic leukemia MNDR-E-MI-46529
MNDR hsa-miR-378a-3p Colorectal cancer MNDR-E-MI-46530
MNDR hsa-miR-378a-3p Sleep deprivation MNDR-E-MI-46531
MNDR hsa-miR-378a-3p Breast cancer her3+ negative MNDR-E-MI-46532
MNDR hsa-miR-378a-3p Duke A MNDR-E-MI-46533
MNDR hsa-miR-378a-3p Tubulovillous adenoma MNDR-E-MI-46534
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter CDK6 Homo sapiens RR00311163
TOP